Acadia Healthcare Company Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Acadia Healthcare Company wird ein jährliches Gewinn- und Umsatzwachstum von 11.6% bzw. 8.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.1% betragen.
Wichtige Informationen
11.6%
Wachstumsrate der Gewinne
10.1%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 20.9% |
| Wachstumsrate der Einnahmen | 8.5% |
| Zukünftige Eigenkapitalrendite | 10.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 22 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
It's Down 29% But Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Could Be Riskier Than It Looks
Nov 02
Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
Oct 27Acadia Healthcare Company (NASDAQ:ACHC) Takes On Some Risk With Its Use Of Debt
Oct 06Acadia Healthcare: Further Scrutiny Of Suspect Practices Will Take Time To Resolve
Sep 27Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Popularity With Investors Is Clear
Sep 14Acadia Healthcare Company (NASDAQ:ACHC) Might Have The Makings Of A Multi-Bagger
Jul 11Is Acadia Healthcare Company (NASDAQ:ACHC) Using Too Much Debt?
Jun 16Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Shareholders Might Be Looking For Exit
May 24Acadia Healthcare: M&A Strategies Facilitate Market Expansion
May 03The Return Trends At Acadia Healthcare Company (NASDAQ:ACHC) Look Promising
Mar 21Acadia Healthcare Company (NASDAQ:ACHC) Seems To Use Debt Quite Sensibly
Feb 12Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Not Quite Adding Up
Dec 27We Like These Underlying Return On Capital Trends At Acadia Healthcare Company (NASDAQ:ACHC)
Dec 06What Does Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Indicate?
Oct 23These 4 Measures Indicate That Acadia Healthcare Company (NASDAQ:ACHC) Is Using Debt Reasonably Well
Sep 13Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Aug 23Do Acadia Healthcare Company's (NASDAQ:ACHC) Earnings Warrant Your Attention?
Jul 24Is There Now An Opportunity In Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Jul 10Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
May 29Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
May 15With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Apr 16What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Apr 03We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Feb 19Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Feb 05With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Jan 08When Should You Buy Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Dec 26Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
Nov 16Returns At Acadia Healthcare Company (NASDAQ:ACHC) Are On The Way Up
Oct 24Here's Why We Think Acadia Healthcare Company (NASDAQ:ACHC) Is Well Worth Watching
Sep 28What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Sep 14We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Aug 17Acadia Healthcare Q2 2022 Earnings Preview
Jul 26Investors Met With Slowing Returns on Capital At Acadia Healthcare Company (NASDAQ:ACHC)
Jul 25Acadia Healthcare: Capitalizing On Major Mental Health Trend
Jul 19Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,769 | 367 | N/A | N/A | 10 |
| 12/31/2025 | 3,443 | 328 | 20 | 577 | 12 |
| 12/31/2024 | 3,160 | 295 | -517 | 126 | 12 |
| 9/30/2024 | 3,123 | 281 | -496 | 129 | N/A |
| 6/30/2024 | 3,057 | -5 | -459 | 104 | N/A |
| 3/31/2024 | 2,993 | -11 | -403 | 97 | N/A |
| 12/31/2023 | 2,929 | -22 | 38 | 462 | N/A |
| 9/30/2023 | 2,861 | -18 | 87 | 460 | N/A |
| 6/30/2023 | 2,778 | 271 | 42 | 363 | N/A |
| 3/31/2023 | 2,698 | 278 | 36 | 348 | N/A |
| 12/31/2022 | 2,610 | 273 | 84 | 381 | N/A |
| 9/30/2022 | 2,529 | 282 | 68 | 365 | N/A |
| 6/30/2022 | 2,449 | 277 | 170 | 434 | N/A |
| 3/31/2022 | 2,380 | 242 | 139 | 375 | N/A |
| 12/31/2021 | 2,314 | 203 | 130 | 374 | N/A |
| 9/30/2021 | 2,262 | 192 | 250 | 463 | N/A |
| 6/30/2021 | 2,223 | 162 | 337 | 560 | N/A |
| 3/31/2021 | 2,132 | 144 | 464 | 689 | N/A |
| 12/31/2020 | 2,090 | 140 | 434 | 659 | N/A |
| 9/30/2020 | 1,230 | 14 | 400 | 592 | N/A |
| 6/30/2020 | 1,459 | 20 | 269 | 469 | N/A |
| 3/31/2020 | 1,757 | 41 | 121 | 335 | N/A |
| 12/31/2019 | 2,008 | 52 | 100 | 333 | N/A |
| 9/30/2019 | 3,071 | -211 | 47 | 341 | N/A |
| 6/30/2019 | 3,054 | -208 | 6 | 325 | N/A |
| 3/31/2019 | 3,031 | -197 | 45 | 385 | N/A |
| 12/31/2018 | 1,905 | 57 | 161 | 414 | N/A |
| 9/30/2018 | 2,993 | 226 | 84 | 414 | N/A |
| 6/30/2018 | 2,949 | 225 | N/A | 429 | N/A |
| 3/31/2018 | 2,899 | 216 | N/A | 415 | N/A |
| 12/31/2017 | 2,836 | 200 | N/A | 400 | N/A |
| 9/30/2017 | 2,815 | 172 | N/A | 373 | N/A |
| 6/30/2017 | 2,833 | 9 | N/A | 366 | N/A |
| 3/31/2017 | 2,873 | 15 | N/A | 360 | N/A |
| 12/31/2016 | 2,811 | 6 | N/A | 361 | N/A |
| 9/30/2016 | 2,603 | -1 | N/A | 358 | N/A |
| 6/30/2016 | 2,348 | 146 | N/A | 332 | N/A |
| 3/31/2016 | 2,046 | 124 | N/A | 281 | N/A |
| 12/31/2015 | 1,794 | 112 | N/A | 240 | N/A |
| 9/30/2015 | 1,594 | 100 | N/A | 188 | N/A |
| 6/30/2015 | 1,409 | 96 | N/A | 177 | N/A |
| 3/31/2015 | 1,169 | 85 | N/A | 126 | N/A |
| 12/31/2014 | 1,005 | 83 | N/A | 115 | N/A |
| 9/30/2014 | 900 | 73 | N/A | 88 | N/A |
| 6/30/2014 | 790 | 62 | N/A | 66 | N/A |
| 3/31/2014 | 754 | 52 | N/A | 72 | N/A |
| 12/31/2013 | 713 | 43 | N/A | 66 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ACHCDas prognostizierte Gewinnwachstum (11.6% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: ACHCDie Erträge des Unternehmens (11.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: ACHCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: ACHCDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: ACHCDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ACHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.1%).